Trial Profile
WHO/MAP/IND/02 Pivotal study to evaluate the immunogenicity and safety of a measles vaccine given by aerosolized inhalation: randomized controlled trial.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Measles virus vaccine live (Primary) ; Measles virus vaccine live (Primary)
- Indications Measles
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Serum Institute of India
- 03 May 2011 Status changed from active, no longer recruiting to completed, as reported in the Clinical Trials Registry - India record.
- 04 May 2010 Status changed from recruiting to active, no longer recruiting, as reported in the Clinical Trials Registry - India record.
- 10 Mar 2010 New trial record